RQ-00000010 for Gastroparesis and Constipation in Parkinson's Disease

Completed · Phase 1 · Has a placebo group

Conditions studied: Parkinson's Disease, Gastroparesis, Constipation

In brief

This is a study to determine the safety and tolerability of a new medicine (RQ10) for gastrointestinal symptoms in Parkinson's disease. The investigators will also begin to look at the effect of this medicine on gastrointestinal problems. The results will determine if future studies are appropriate. In this study, RQ10 will be compared to a placebo (a look-alike inactive substance). Participation will include multiple office visits. Approximately 48 people will participate.

Key facts

Study ID
NCT02838797
Run by
Virginia Commonwealth University
People needed
51
Starts
2016-06-01
Expected to finish
2019-08-20
Last updated by the study team
2019-10-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.